Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
326.40    -9.00 (-2.68%)
Bid:
326.60
Ask:
327.40
Spread: 0.80 (0.245%)
Market Cap: £715.04m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

US SEC Declares Registration Statement Effective

1 Oct 2020 07:00

RNS Number : 6974A
Burford Capital Limited
01 October 2020
 

 

 

1 October 2020

 

 

BURFORD CAPITAL ANNOUNCES US REGISTRATION STATEMENT DECLARED EFFECTIVE BY SEC

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the leading global finance and asset management firm focused on law, today announces that its US registration statement was declared effective by the US Securities and Exchange Commission ("SEC") at 4.00pm EDT / 9.00pm BST on 30 September 2020. That concludes the process of registering Burford's ordinary shares under the US Securities and Exchange Act of 1934, as amended.

 

Burford's ordinary shares have been approved for listing on the New York Stock Exchange ("NYSE") and are expected to commence trading on or around 19 October 2020, in addition to their continuing trading on London Stock Exchange AIM.

 

Shareholders are advised that they are now subject to the disclosure regime under US securities laws, including any applicable beneficial ownership reporting requirements, even though Burford's shares are not yet trading in the US.

 

When trading commences on the NYSE, in both listing venues Burford's shares will trade under the following information:

 

ISSUER: BURFORD CAPITAL LTDDESCRIPTION: ORD NPV

TICKER (both NYSE and AIM): BURSEDOL: BMGYLN9ISIN: GG00BMGYLN96

CUSIP: G17977 110

OPOL: XLONCFICODE2015: ESVUFRFISN: BURFD CAP/NPV VTG FPD

 

Christopher Bogart, CEO of Burford, commented:

"We are delighted to have completed the process to obtain a US listing and look forward to expanding our pool of investors."

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

 

 

For further information, please contact:

 

Burford Capital Limited

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations, EMEA and Asia - email

+44 (0)20 3530 2023

Jim Ballan, Head of Investor Relations, Americas - email

+1 (646) 793 9176

Numis Securities Limited - NOMAD and Joint Broker

+44 (0)20 7260 1000

Huw Jeremy (NOMAD)

Charlie Farquhar / Jonathan Abbott (Joint Broker)

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information about Burford: www.burfordcapital.com

 

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRKZGFLFGLGGZZ
Date   Source Headline
1st Jul 20255:46 pmRNSUS Budget Bill Adopted Without Lit Fin Provisions
1st Jul 20257:15 amRNSUpdate Re US Budget Bill and YPF Ruling
30th Jun 20258:00 amRNSFurther Statement Re US Budget Reconciliation Bill
30th Jun 20257:00 amRNSChange of Nominated Adviser
17th Jun 20257:00 amRNSStatement Re US Budget Reconciliation Bill
10th Jun 20251:00 pmRNSIssue of Equity & Director/PDMR Shareholding
6th Jun 202511:30 amRNSCompleted Purchases of Shares
5th Jun 20251:00 pmRNSIntended Purchases of Ordinary Shares
30th May 202512:00 pmRNSSterling FX Rate for 2024 Final Dividend
16th May 20251:30 pmRNSDirector/PDMR Shareholding
15th May 20251:00 pmRNSResult of AGM
14th May 202512:37 pmRNSMSCI Change to BUR Index Country Classification
7th May 20251:00 pmRNS1Q25 Financial Results
6th May 202512:00 pmRNSNotice of Retail Shareholder Audio Webcast
30th Apr 202512:00 pmRNSNotice of 1Q25 Results & Results Call Details
28th Apr 202512:00 pmRNSAdditional Definitive Proxy Soliciting Materials
10th Apr 202512:00 pmRNSIssue of Equity & Director/PDMR Shareholding
4th Apr 20257:00 amRNSDefinitive Proxy Materials and 2024 Annual Report
3rd Apr 202512:00 pmRNSStrategic Update at 2025 Investor Day
17th Mar 202511:00 amRNSPartial Repurchase and Cancellation of Bonds
17th Mar 202511:00 amRNSIntended Purchases of Ordinary Shares
11th Mar 20257:30 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSFiling of 2024 Annual Report on Form 10-K
3rd Mar 202512:00 pmRNSAnnual Results for Year Ended December 31, 2024
25th Feb 20257:00 amRNSNotice of 2024 Results & Reporting Change Preview
4th Feb 20252:00 pmRNSBurford Capital announces 2025 Investor Day
31st Jan 20257:30 amRNSDirector/PDMR Shareholding
27th Dec 202411:00 amRNSIssue of New Shares in Connection With LTIP
17th Dec 202411:00 amRNSDirector/PDMR Shareholding
22nd Nov 202412:00 pmRNSDirector/PDMR Shareholding
15th Nov 20241:15 pmRNSPartial Repurchase and Cancellation of Bonds
8th Nov 202412:00 pmRNSSterling Conversion Rate for 2024 Interim Dividend
7th Nov 202412:46 pmRNS3Q24 Results & Quarterly Report
7th Nov 202412:03 pmRNSBurford Statement re YPF Matter
28th Oct 202412:00 pmRNSNotice of 3Q24 Results & Results Call Details
17th Oct 202411:00 amRNS2025 AGM Logistics
1st Oct 202411:00 amRNSDirector/PDMR Shareholding
25th Sep 20241:15 pmRNSIssue of New Shares in Connection With LTIP
23rd Aug 202412:00 pmRNSResult of Meeting
23rd Aug 202411:30 amRNSDirector/PDMR Shareholding
21st Aug 202411:00 amRNSDirector/PDMR Shareholding
8th Aug 202412:00 pmRNS2Q24 Results & Quarterly Report
5th Aug 202412:00 pmRNSTransition to US Domestic Issuer Status
31st Jul 202412:00 pmRNSNotice of 2Q24 Results & Results Call Details
22nd Jul 202412:00 pmRNSNotice of EGM
10th Jul 20247:00 amRNSAppointment of KPMG LLP as Independent Auditor
2nd Jul 202411:00 amRNSHolding(s) in Company
28th Jun 202412:00 pmRNSIssue of New Shares for LTIP & Adjusted PDMR LTIP
21st Jun 20241:00 pmRNSIssue of New Shares Pursuant to DCP & PDMR Notices
6th Jun 20241:30 pmRNSPartial Repurchase and Cancellation of Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.